| 4.59 0.09 (2%) | 03-12 13:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.57 | 1-year : | 6.13 |
| Resists | First : | 4.77 | Second : | 5.25 |
| Pivot price | 4.47  |
|||
| Supports | First : | 4 | Second : | 3.33 |
| MAs | MA(5) : | 4.46  |
MA(20) : | 4.55 |
| MA(100) : | 4.71 |
MA(250) : | 3.86 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 51.8 |
D(3) : | 47 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 5.69 | Low : | 2.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SOPH ] has closed below upper band by 39.0%. Bollinger Bands are 27% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.63 - 4.65 | 4.65 - 4.66 |
| Low: | 4.29 - 4.3 | 4.3 - 4.32 |
| Close: | 4.47 - 4.5 | 4.5 - 4.52 |
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Sun, 08 Mar 2026
Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks
Fri, 06 Mar 2026
SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm
Wed, 04 Mar 2026
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey
Tue, 03 Mar 2026
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka
Tue, 03 Mar 2026
BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com
Tue, 03 Mar 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 68 (M) |
| Shares Float | 51 (M) |
| Held by Insiders | 6.4 (%) |
| Held by Institutions | 50.4 (%) |
| Shares Short | 226 (K) |
| Shares Short P.Month | 53 (K) |
| EPS | -1.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.68 |
| Profit Margin | -102.3 % |
| Operating Margin | -91.8 % |
| Return on Assets (ttm) | -25.6 % |
| Return on Equity (ttm) | -86.1 % |
| Qtrly Rev. Growth | 22.7 % |
| Gross Profit (p.s.) | 0.72 |
| Sales Per Share | 1.08 |
| EBITDA (p.s.) | -1.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -37 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -4.07 |
| PEG Ratio | 0 |
| Price to Book value | 6.59 |
| Price to Sales | 4.21 |
| Price to Cash Flow | -8.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|